According to Zhitong Finance App, China Resources Pharmaceutical (03320.HK) announced that China Resources Pharmaceutical Holdings Co., Ltd. (China Resources Pharmaceutical Holdings), a wholly-owned subsidiary of the company, has completed the public offering of the second 2026 corporate bonds in China. The second 2026 corporate bond with a principal amount of RMB 900 million has been issued, with a term of three years and an annual coupon interest rate of 1.48%.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.